Physician profile
Stella Jane Cloud
NPI 1750453494
$615.52
in general payments reported to CMS, 2019-2025
14 companies · $65.42 in 2025
The $65.42 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $289 · 2022: $76.34 · 2023: $120 · 2024: $64.87 · 2025: $65.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $250.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $201.44 | 2021-2023 | |
| Organon LLC | $110.23 | 2021-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $55.68 | 2024-2025 | Gemtesa |
| Exact Sciences Corporation | $43.47 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Therapeuticsmd, INC. | $33.61 | 2021 | |
| Agile Therapeutics, INC. | $32.75 | 2021 | |
| Myriad Genetic Laboratories, INC. | $30.05 | 2023 | Myrisk |
| Astellas Pharma US INC | $21.88 | 2023 | Veozah |
| Scynexis, INC. | $21.13 | 2022 | |
| Pfizer INC. | $15.91 | 2024 | |
| Sage Therapeutics, LLC | $14.84 | 2021 | |
| Abbott Laboratories | $14.00 | 2022 | |
| Merck Sharp & Dohme LLC | $13.59 | 2021 | |
| Mayne Pharma Commercial LLC | $6.94 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stella Cloud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.